Notable Labs, Ltd. (NASDAQ:NTBL) Short Interest Update

Notable Labs, Ltd. (NASDAQ:NTBL) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 622,000 shares, a growth of 22.0% from the August 31st total of 509,900 shares. Based on an average daily trading volume, of 89,400 shares, the short-interest ratio is presently 7.0 days. Approximately 12.0% of the company’s stock are short sold.

Notable Labs Stock Down 5.9 %

Shares of NASDAQ NTBL traded down $0.03 during trading hours on Monday, hitting $0.42. 4,050 shares of the company’s stock were exchanged, compared to its average volume of 232,089. Notable Labs has a 1-year low of $0.40 and a 1-year high of $10.08. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.77 and a quick ratio of 2.77. The company’s 50-day moving average price is $0.53 and its 200-day moving average price is $0.86.

Notable Labs (NASDAQ:NTBL) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.55) earnings per share for the quarter. As a group, research analysts anticipate that Notable Labs will post -0.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, JMP Securities cut Notable Labs from an “outperform” rating to a “market perform” rating in a research report on Friday, September 20th.

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.